OGN - Organon in charts: Biosimilars revenue rises by ~49% and Women's Health revenue by 7% in Q4
2024-02-15 07:50:53 ET
More on Organon
- Organon & Co. (OGN) JPMorgan 42nd Annual Healthcare Conference (Transcript)
- Organon: What I'm Looking For In This 8% Yield In 2024
- High Risk, High Reward: Why 8.5%-Yielding Organon Could Be Up To 90% Undervalued
- Organon beats top-line and bottom-line estimates; initiates FY24 outlook
- Organon gaining momentum ahead of Q4 earnings